Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis
多那非尼与索拉非尼在不可切除肝细胞癌三联疗法中的比较:一项倾向评分匹配的多中心分析
期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-025-03767-5
Wen, Yaohong; Zhou, Shuyi; Xu, Yuyan; Zhang, Cheng; Feng, Zhoubin; Song, Yinghui; Ding, Bai; Peng, Chuang; Tan, Hongkun; Wang, Chunming; Feng, Jianan; Pei, Jingyuan; He, Guolin; Fu, Shunjun; Wang, Lvhuan; Cai, Lei; Liu, Sulai; Pan, Mingxin